Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 11, 2021
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
[ Mon, Oct 11th 2021
] - WOPRAI
Sun, October 10, 2021
[ Sun, Oct 10th 2021
] - WOPRAI
Fri, October 8, 2021
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
[ Fri, Oct 08th 2021
] - WOPRAI
Salveen Richter Downgraded (ALLO) to Hold and Decreased Target to $20 on, Oct 8th, 2021
Salveen Richter of Goldman Sachs, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Hold and Decreased Target from $71 to $20 on, Oct 8th, 2021.
Salveen has made no other calls on ALLO in the last 4 months.
There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, 0 agree with Salveen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Salveen
- Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $36 on, Friday, September 24th, 2021
